Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. - Wikidata - awgldk - TriplyDB

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

http://www.wikidata.org/entity/Q35568881

about

Interventions for enhancing medication adherence Interventions for enhancing medication adherence Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature.The prevention of type 2 diabetes.Factors affecting medication adherence: patient perspectives from five veterans affairs facilities.Importance of including early nonadherence in estimations of medication adherence.Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study Chromium Picolinate for the Prevention of Type 2 Diabetes.Sex differences in type 2 diabetes: focus on disease course and outcomes Chromium level in prediction of diabetes in pre-diabetic patients.Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial Lifestyle and psychosocial risk factors predict non-adherence to medication Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus.Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system.Improving the validity of determining medication adherence from electronic health record medications orders.Factors related to high and low levels of drug adherence according to patients with type 2 diabetes.Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative.Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study.How patient cost-sharing trends affect adherence and outcomes: a literature review.The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.Feasibility of web-based technology to assess adherence to clinic appointments in youth with sickle cell disease.Integrating interactive web-based technology to assess adherence and clinical outcomes in pediatric sickle cell disease.Successful self-management among non-insulin-treated adults with Type 2 diabetes: a self-regulation perspective.Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study.Medicare Star excludes diabetes patients with poor CVD risk factor control.Telephone Intervention to Improve Diabetes Control: A Randomized Trial in the New York City A1c Registry Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes Medication taking and diabetes: a systematic review of the literature.Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes.Strategies for preventing type 2 diabetes: an update for clinicians.Adherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran.Development and Usability of REACH: A Tailored Theory-Based Text Messaging Intervention for Disadvantaged Adults With Type 2 Diabetes.Ruboxistaurin: PKC-beta inhibition for complications of diabetes.Predictors of medication adherence in an urban Latino community with healthcare disparities.Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus.

P2860

Q24187912-8B8727F7-A6D0-4289-A6A0-1F26451D40BE Q24243296-2A7A2126-1342-45B5-ACA2-97D750721171 Q26822066-89444CB9-13C1-4AEC-879C-EB987FA722B6 Q26864768-2168D5C0-04F1-43A6-9FD0-19B13F32B6AA Q30484253-77816188-C7BF-4288-A99C-32990DA205EE Q30600372-81DF280D-D310-43EF-9040-05471C7D73D2 Q33852705-945DDD07-9BAF-4678-BEFA-75782DB524A0 Q34189448-54506113-7CD0-430F-9373-BD95AFBCFE4E Q34213716-6D385AE9-34FE-4001-A2F0-77A3260117C2 Q34229975-416529D6-7914-414B-9EC5-A6CA0782A218 Q34659680-E9B26F5F-6EBA-4AA5-B0B5-B22246F5389F Q34713962-97FB9CF5-ADA4-4261-A301-DEAAF08E9B8E Q35009065-D8F50C7A-2E52-4EB1-B505-E1341D0AB27B Q35053877-90D35997-180E-41A1-BE7B-FE7CAF0267AC Q35113964-9BCCDBA2-23F4-400D-9700-77F72475E015 Q35177409-A76BB07A-57E4-4AD4-A0EB-8E0CD48FEB0C Q35200266-A01FDE93-F278-4FF5-9E8B-97F3127E6D0B Q35291953-4D7E6295-3307-40F3-9904-46BB05D69359 Q35519010-BC9BE9D3-3CEE-4F0A-8EDD-8C3CE4C4805E Q35649045-A28C0FDB-B291-4DF0-90BC-48439685431A Q35656450-3DC41835-ED3A-45B9-88B5-4624B4ABD357 Q35748278-984BE5DD-CC67-4272-83A8-CC36C4082682 Q35752951-946570DF-A59A-439E-8953-241E1909BEA0 Q35811990-0CFA958A-3D16-4CE9-ADEE-91336996D43F Q35851069-8FBCF085-21D7-4994-978F-E67E69CBCE14 Q36023769-A490C536-9099-42B5-8162-BE94E2B49D30 Q36054485-F8406ED2-7C68-4D39-9C8B-21ACAC572C0D Q36209136-1BC2F1A7-258B-492B-B8DD-ED19CAF8613D Q36270909-BA2F4F47-409D-4FDA-B7DE-AD88D5FD3619 Q36307600-AB0D8790-92CC-4D09-A75E-6E39A96F8BD5 Q36862877-566974F1-E9C5-4AB9-98C9-CC9C2E780DAD Q37012091-60A89D47-138C-41CE-91D2-4447447DA21A Q37023520-0CA65C9A-6BA2-4C6D-8B9B-B3EE7D4A91A6 Q37102861-139466E8-BFCE-4B3A-BA5C-147687A004E4 Q37117608-BF80BEF8-174B-4F0C-84D1-CBDD7A23A838 Q37268117-ADD3A2E5-A83F-4B73-8A3F-AD89C0B48B90 Q37277710-2E4A5031-A1FE-4765-83A7-7A3F26F0CA5A Q37636163-6A6A0485-0775-4535-9F1F-4313702537D1 Q37954176-7363A444-6C89-4F41-95F2-80EB361DA55B Q38086816-8964D188-4CEE-4A12-873C-4EFF10E8B547

P2860

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

http://www.wikidata.org/entity/Q35568881

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Adherence to preventive medica ...... e Diabetes Prevention Program.

@ast

Adherence to preventive medica ...... e Diabetes Prevention Program.

@en

type

label

Adherence to preventive medica ...... e Diabetes Prevention Program.

@ast

Adherence to preventive medica ...... e Diabetes Prevention Program.

@en

prefLabel

Adherence to preventive medica ...... e Diabetes Prevention Program.

@ast

Adherence to preventive medica ...... e Diabetes Prevention Program.

@en

P1433

Q35568881-FB48587B-BAF8-4015-9ECA-FD403C344DDA

P1476

Q35568881-CA07C5A9-761B-4389-BD14-66BBF36A115D

P2093

Q35568881-56A002F6-F239-4E60-B8A5-057BA0C9E4BA

Q35568881-61EE391D-D713-425C-A773-B4DB1C5B7D26

Q35568881-965476E3-1F11-4ECA-8988-F4362DBF8ABD

Q35568881-A54923DF-8FBA-4660-A36E-E5D8D3E66B9B

Q35568881-D7424FBA-4256-466C-AF27-ED35904B2424

Q35568881-E31C74CF-97FF-48D1-8C42-AF82CA5961FE

Q35568881-E4674CDF-00B9-40AE-9481-4ACFBF7ED7BE

Q35568881-FD0408DD-9C45-40E2-A296-2C15C47ABFF7

P2860

Q35568881-1B523040-BCFD-4EB2-99AF-D8F0068E39F1

Q35568881-3FB6BF7C-2941-4816-9140-B085127FE362

Q35568881-4088DF5C-0BA2-44B5-AFDF-C3ACC1AAE1DA

Q35568881-4EE3358A-41D3-4A26-939A-933919AAEDAA

Q35568881-6E61DCEE-848B-4B56-95EC-6FD9815F46CF

Q35568881-72DA85EC-0B59-451F-B4C4-E82828AC112B

Q35568881-89A7C2FF-5E6E-4FEE-9B80-BEDA30CFD1B9

Q35568881-8D7357F7-01DE-4EAC-BAB3-E28DAB84FA81

Q35568881-9D30A1E0-96BF-48DF-8C6F-63793F0ED030

Q35568881-B2D825C5-563F-4B15-ADEE-467546B37A27

P304

Q35568881-7FF5FBBB-661D-4792-9F8F-6E28BE0FBA01

P31

Q35568881-66FD1E2A-58AC-4D2E-B333-973D0BBD719F

P356

Q35568881-D973F696-1DFC-4D52-A9BF-5D0E3264305F

P407

Q35568881-FF3564CF-0672-4309-870F-506156FB801B

P433

Q35568881-76B2119E-B351-4FC4-85FF-4ED1CBBA44C4

P478

Q35568881-DE052000-F2C4-414B-B01A-9A9F206D5563

P50

Q35568881-17FE405C-C111-4F9A-9102-C29704A2EFC1

Q35568881-66A40647-1C9A-40D3-A238-2153ADBDC226

P577

Q35568881-23992694-16E5-4BF1-9FA1-EFB51EDA026E

P5875

Q35568881-DD58F9F4-C264-4748-8BF9-A1D93E9DAF68

P698

Q35568881-636938C9-10C9-4AD8-9FC5-DF42F670AD2D

P932

Q35568881-0F1AEE28-001E-49F6-A60B-899DD5C952F1

P356

P1433

P1476

Adherence to preventive medica ...... e Diabetes Prevention Program.

@en

P2093

Elizabeth A Walker

http://www.w3.org/2001/XMLSchema#string

Jill Crandall

http://www.w3.org/2001/XMLSchema#string

Kellie Smith

http://www.w3.org/2001/XMLSchema#string

M Kaye Kramer

http://www.w3.org/2001/XMLSchema#string

Mariana Kiefer Johnson

http://www.w3.org/2001/XMLSchema#string

Mark Molitch

http://www.w3.org/2001/XMLSchema#string

Sharon Edelstein

http://www.w3.org/2001/XMLSchema#string

Yong Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: An Update

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

Adherence to Medication

Interventions to enhance patient adherence to medication prescriptions: scientific review.

Medication compliance and older people: a review of the literature.

Adherence in chronic disease.

The Diabetes Prevention Program (DPP): description of lifestyle intervention

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

P304

1997-2002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC06-0454

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Abbas E Kitabchi

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6852719

http://www.w3.org/2001/XMLSchema#string

P698

16936143

http://www.w3.org/2001/XMLSchema#string

P932

1762037

http://www.w3.org/2001/XMLSchema#string